“Treatment-resistant depression” is a phrase many patients hear after they have tried several antidepressants without lasting relief. It is usually meant descriptively — a way of naming that the standard approaches have not worked. But the label can quietly harden into something heavier: a sense that the depression itself is the problem, that the patient is the exception, that the options have run out.
In clinical terms, depression is typically called treatment-resistant after two adequate medication trials have failed to produce a meaningful response. The important word in that definition is adequate — and in practice, it is the word that most often does not hold up. Before depression is accepted as truly resistant, it is worth asking a different question first: resistant to what, exactly?
The label often describes the treatment, not the illness
A surprising amount of what gets called treatment-resistant turns out to be under-treatment. Medication trials are frequently stopped before they had a fair chance — a dose that never reached a therapeutic range, or a trial abandoned after a few weeks when antidepressants commonly need longer to show their full effect. Two trials that were each cut short are not the same as two adequate trials, even though they are often counted that way.
Adherence is part of this picture too, and not as a matter of blame. Side effects, cost, confusing instructions, and the simple difficulty of taking a medication daily while depressed all shape whether a trial was ever truly tested. None of this means the patient failed. It means the trial did not happen the way the chart suggests it did.
The most consequential question: is the diagnosis complete?
When antidepressants reliably fail to help, one of the most important possibilities is that the depression is not unipolar depression at all. Bipolar disorder — particularly bipolar II, where the elevated periods are subtle and easily missed — frequently presents first as recurrent depression. Treated with an antidepressant alone, it tends to respond poorly, and in some cases the medication can worsen mood instability. A history of depressions that came on early, recurred often, or never fully fit the usual pattern is worth a careful second look.
Other conditions hide inside a depression diagnosis in the same way. Unrecognized ADHD, the aftermath of trauma, persistent anxiety, or ongoing substance use can each produce or sustain depressive symptoms that antidepressants alone will not resolve. When the diagnostic picture is incomplete, no amount of adjusting a single medication will reach what is actually driving the symptoms.
Medical contributors are easy to miss — and very treatable
Depression does not exist apart from the body. Thyroid dysfunction, obstructive sleep apnea, certain vitamin deficiencies, chronic pain, hormonal shifts, and the side effects of unrelated medications can all produce or deepen depressive symptoms. These contributors are common, frequently overlooked in a narrowly psychiatric evaluation, and often very responsive once identified.
This is one place where a dual lens on psychiatric and medical health earns its keep. Reviewing the medical contributors to mood is not a separate referral to chase down later — it is part of understanding why the depression has not lifted. When one of these factors is present and unaddressed, the depression can look resistant while the real issue has simply not been named.
What a careful re-evaluation actually looks for
A re-evaluation is not another medication switch. It is a structured look at the whole history: when the depressions began and how they have behaved over time, every medication tried with its actual dose and duration and why it was stopped, the family history, the sleep, the substances, the medical background, and the symptoms that never quite fit the working diagnosis. The goal is to find what an earlier, faster assessment may not have had time to find.
Often that process reframes the situation entirely. Depression that looked resistant turns out to be a trial that was never optimized, a diagnosis that was incomplete, or a medical contributor that was never reviewed — each of which points to a clear and different next step.
Sometimes depression is genuinely difficult — and that is not the end of the road
None of this is to say that true treatment-resistant depression does not exist. It does, and some people arrive having already had a genuinely thorough work-up. But even then, “resistant” is not the same as “out of options.” A precise understanding of what has and has not been tried is exactly what makes the next, more specialized steps possible rather than guessed at.
If you have been told your depression is treatment-resistant and you have never had an evaluation that examined all of this carefully, that is worth knowing. In a meaningful number of cases, the depression was never resistant. The evaluation was simply never thorough enough.
A thorough re-evaluation of depression that hasn’t responded.
Diagnostic clarification and medication reassessment appointments are available via telehealth to adults in California and Hawaiʻi. In-network with HMSA and AlohaCare in Hawaiʻi. Select your state to begin.